McDowell Arlene, McLeod Bernie J
School of Pharmacy, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.
Adv Drug Deliv Rev. 2007 Sep 30;59(11):1121-32. doi: 10.1016/j.addr.2007.06.012. Epub 2007 Aug 16.
Oral formulations are typically based on studies from eutherian animal models. This review introduces information relating to oral formulations for a marsupial species, the Australian brushtail possum (Trichosurus vulpecula) that has arisen from research into new methods for controlling this species - a major vertebrate pest in New Zealand. Morphologically, the gastrointestinal tract of the brushtail possum is similar to that of hindgut fermenting eutherian species, but there are some striking differences in function. Limited data suggests that the pharmacokinetics and bioavailability of administered drugs are similar to that in eutherian species, but there is some evidence that possums may have specific mechanisms for handling the intake of plant toxins and xenobiotics. The development of oral formulations for a free-ranging pest species presents several challenges above those encountered in the development of therapeutic formulations for humans and domestic animals. Use of a marsupial animal model may lead to new strategies for oral formulations in humans.
口服制剂通常基于真兽类动物模型的研究。本综述介绍了有关一种有袋类动物——澳大利亚帚尾袋貂(Trichosurus vulpecula)口服制剂的信息,这些信息来自于对控制该物种新方法的研究,帚尾袋貂是新西兰一种主要的脊椎动物害虫。在形态上,帚尾袋貂的胃肠道与后肠发酵的真兽类物种相似,但在功能上存在一些显著差异。有限的数据表明,给药药物的药代动力学和生物利用度与真兽类物种相似,但有证据表明,袋貂可能具有处理植物毒素和外源性物质摄入的特定机制。为一种自由放养的害虫物种开发口服制剂面临着一些挑战,这些挑战比为人类和家畜开发治疗性制剂时遇到的挑战更多。使用有袋类动物模型可能会为人类口服制剂带来新的策略。